Lindbrook Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $20.9K | Hold |
1,164
| – | – | ﹤0.01% | 1329 |
|
|
2024
Q4 | $20.3K | Hold |
1,164
| – | – | ﹤0.01% | 1284 |
|
|
2024
Q3 | $16.3K | Hold |
1,164
| – | – | ﹤0.01% | 1405 |
|
|
2024
Q2 | $9.57K | Buy |
1,164
+728
| +167% | +$5.98K | ﹤0.01% | 1650 |
|
|
2024
Q1 | $3.36K | Buy |
+436
| New | +$3.36K | ﹤0.01% | 2062 |
|
|
2023
Q4 | – | Sell |
-99
| Closed | -$885 | – | 2837 |
|
|
2023
Q3 | $885 | Buy |
99
+62
| +168% | +$554 | ﹤0.01% | 2386 |
|
|
2023
Q2 | $568 | Buy |
+37
| New | +$568 | ﹤0.01% | 2483 |
|
|
2022
Q4 | – | Sell |
-223
| Closed | -$5K | – | 3036 |
|
|
2022
Q3 | $5K | Buy |
+223
| New | +$5K | ﹤0.01% | 1695 |
|
|
2021
Q4 | – | Sell |
-1,500
| Closed | -$36K | – | 2209 |
|
|
2021
Q3 | $36K | Buy |
+1,500
| New | +$36K | 0.01% | 542 |
|